Pawlak, D <br/><br/>
A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats.  [electronic resource] 

 -  Thrombosis research  Jun 1998 
 - 259-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0049-3848 
<br/><br/><label>Standard No.: </label>10.1016/s0049-3848(98)00037-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aorta, Abdominal<br/>Bleeding Time<br/>Ketanserin--pharmacology<br/>Male<br/>Piperidines--pharmacology<br/>Platelet Aggregation--drug effects<br/>Rats<br/>Rats, Wistar<br/>Receptor, Serotonin, 5-HT2A<br/>Receptors, Serotonin--drug effects<br/>Serotonin--metabolism<br/>Serotonin Antagonists--pharmacology<br/>Thrombophlebitis--prevention & control<br/>Thrombosis--prevention & control<br/>Triazines--pharmacology